Table 1 Demographics of the participants
CEZ group n = 265 | Non-CEZ group n = 316 | P value | |
|---|---|---|---|
Age, years | 76 (8.9) | 77 (8.2) | 0.06 |
Male/female, (male%) | 101/164 (38.1%) | 120/196 (38%) | 1.00 |
Body mass index, kg/m2 | 23.8 (4.0) | 23.1 (3.3) | 0.04 |
Number of operated eyes | |||
Unilateral eye/bilateral eyes, (unilateral eye%) | 105/160 (39.6%) | 125/191 (39.6%) | 1.00 |
History of allergies | |||
Antibiotics, n (%) Non-antibiotics, n (%) Foods, n (%) | 5 (1.9%) 16 (6.0%) 18 (6.8%) | 10 (3.2%) 28 (8.9%) 19 (6.0%) | 0.43 0.21 0.74 |
Diabetes mellitus, n (%) | 60 (22.6%) | 83 (26.3%) | 0.33 |
HbA1c, % | 6.8 (1.0) | 6.8 (0.8) | 0.81 |
Hemodialysis, n (%) | 4 (1.5%) | 3 (0.9%) | 0.71 |
Concurrent medication | |||
Steroids, n (%) | 16 (6.0%) | 18 (5.7%) | 0.86 |
Immunosuppressants, n (%) | 10 (3.8%) | 12 (3.8%) | 1.00 |
Anticancer drugs, n (%) | 7 (2.6%) | 6 (1.9%) | 0.58 |
Patients with preoperative eye drops, patient (%) | 264 (99.6%) | 311 (98.4%) | 0.23 |
Length of stay for hospitalization | |||
Unilateral eye surgery | 3 [2–8] | 2 [2–6] | < 0.01 |
Bilateral eyes surgery | 6 [4–9] | 5 [2–12] | < 0.01 |
Duration of postoperative antibiotic eye drops, months | 1 [1–3] | 1 [1–4] | < 0.01 |